Literature DB >> 7084220

Synthesis and characterization of neurotensin analogues for structure/activity relationship studies. Acetyl-neurotensin-(8--13) is the shortest analogue with full binding and pharmacological activities.

C Granier, J van Rietschoten, P Kitabgi, C Poustis, P Freychet.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7084220     DOI: 10.1111/j.1432-1033.1982.tb05913.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


× No keyword cloud information.
  16 in total

1.  Creation and functional screening of a multi-use peptide library.

Authors:  C K Jayawickreme; G F Graminski; J M Quillan; M R Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

2.  Parallel secretion of endogenous 5-hydroxytryptamine and histamine from mast cells stimulated by vasoactive peptides and compound 48/80.

Authors:  R E Carraway; D E Cochrane; C Granier; P Kitabgi; E Leeman; E A Singer
Journal:  Br J Pharmacol       Date:  1984-02       Impact factor: 8.739

3.  Neurotensin peptides antagonistically regulate postsynaptic dopamine D2 receptors in rat nucleus accumbens: a receptor binding and microdialysis study.

Authors:  X M Li; L Ferraro; S Tanganelli; W T O'Connor; U Hasselrot; U Ungerstedt; K Fuxe
Journal:  J Neural Transm Gen Sect       Date:  1995

4.  Investigation of the Biological Impact of Charge Distribution on a NTR1-Targeted Peptide.

Authors:  Yinnong Jia; Wenting Zhang; Wei Fan; Susan Brusnahan; Jered Garrison
Journal:  Bioconjug Chem       Date:  2016-10-21       Impact factor: 4.774

5.  In Search of the Optimal Macrocyclization Site for Neurotensin.

Authors:  Marc Sousbie; Élie Besserer-Offroy; Rebecca L Brouillette; Jean-Michel Longpré; Richard Leduc; Philippe Sarret; Éric Marsault
Journal:  ACS Med Chem Lett       Date:  2018-01-29       Impact factor: 4.345

6.  Conformational Changes in Tyrosine 11 of Neurotensin Are Required to Activate the Neurotensin Receptor 1.

Authors:  Fabian Bumbak; Trayder Thomas; Billy J Noonan-Williams; Tasneem M Vaid; Fei Yan; Alice R Whitehead; Shoni Bruell; Martina Kocan; Xuan Tan; Margaret A Johnson; Ross A D Bathgate; David K Chalmers; Paul R Gooley; Daniel J Scott
Journal:  ACS Pharmacol Transl Sci       Date:  2020-04-29

7.  Immunological and biochemical characterization of processing products from the neurotensin/neuromedin N precursor in the rat medullary thyroid carcinoma 6-23 cell line.

Authors:  J N Bidard; F de Nadai; C Rovere; D Moinier; J Laur; J Martinez; J C Cuber; P Kitabgi
Journal:  Biochem J       Date:  1993-04-01       Impact factor: 3.857

Review 8.  Drug-induced hypothermia in stroke models: does it always protect?

Authors:  Meijuan Zhang; Haiying Wang; Jinbing Zhao; Cong Chen; Rehana K Leak; Yun Xu; Peter Vosler; Jun Chen; Yanqin Gao; Feng Zhang
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-05-01       Impact factor: 4.388

9.  Preventive Effect of Two New Neurotensin Analogues on Parkinson's Disease Rat Model.

Authors:  Maria Lazarova; Andrey Popatanasov; Radoslav Klissurov; Svetlana Stoeva; Tamara Pajpanova; Reni Kalfin; Lyubka Tancheva
Journal:  J Mol Neurosci       Date:  2018-10-30       Impact factor: 3.444

10.  PK20, a new opioid-neurotensin hybrid peptide that exhibits central and peripheral antinociceptive effects.

Authors:  Patrycja Kleczkowska; Piotr Kosson; Steven Ballet; Isabelle Van den Eynde; Yuko Tsuda; Dirk Tourwé; Andrzej W Lipkowski
Journal:  Mol Pain       Date:  2010-12-06       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.